When: November 3rd-6th
Where: Orlando, FL
Poster (PO0402): Vascular Calcification, Nephrolithiasis, Bone: Severe bone loss occurs in slow, but not in fast, chronic kidney disease progression. Hao-Hsuan Tsai, D. Kentrup, X. Wang, B. Hunt-Tobey, J. Spindler, J. Von Drasek, V. David, A Martin.
Oral Presentation (OR0400): Advances in Mineral Metabolism and Nephrolithiasis: Hepatocyte Nuclear Factor 4 alpha 2 is a novel osteoblast transcription factor that plays a role in CKD-MBD. Marta Martinez-Calle, G. Courbon, B. Hunt-Tobey, J. Spindler, X. Wang, L. M. dos Reis, C. S.W. Martins, R. M.A. Moyses, A. Martin, V. David.
Poster (PO0200): Anemia and Iron Metabolism: Inflammation-induced alterations in erythropoiesis at the single cell level. Jane Joy Thomas, G. Courbon, A. Martin, V. David.
Poster (PO0401): CKD-MBD: Targets and Outcomes: Differential regulation of FGF23 production and cleavage by iron and EPO in anemic mice. Bridget Hunt-Tobey, M. Martinez Calle, G. Courbon, J. Spindler, J. Von Drasek, X. Wang, A. Martin, V. David
Oral Presentation (OR0400): Advances in Mineral Metabolism and Nephrolithiasis: Estrogen protects female mice with CKD from developing FGF23-induced left ventricular hypertrophy. Dominik Kentrup, G. Courbon, X. Wang, B. Hunt-Tobey, V. David, A. Martin
Poster (PO656): Paracrine FGF23 Signaling Suppresses Erythropoiesis in Iron Deficiency Anemia. Guillaume Courbon, J. Spindler, J. Von Drasek, P. Ji, A. Martin, V. David
For More info Visit: https://www.asn-online.org/education/kidneyweek/